HeartSciences Named “Start-Up to Watch”

SOUTHLAKE, Texas–(BUSINESS WIRE)–HeartSciences is delighted to have been highlighted as “Start-Up to Watch” in the June 8, 2018 issue of the MedTech Strategist. The article titled “HEARTSCIENCES: ARTIFICIAL INTELLIGENCE IMPROVES FRONTLINE RISK STRATIFICATION FOR HEART DISEASES” discusses HeartSciences’ role in addressing the current challenges and significant unmet need to identify heart disease at an early stage and reduce the…

Read More

White House Proposes 30% Cut to FDA Headcount

The Trump administration this week submitted a proposal that would cut the budget and staff at the FDA, as well as reorganizing the agency to remove food regulation from its purview, according to a new Endpoints News report. The proposal would cut $1.3 billion in resources from the agency and 5,000 members of its staff and leave…

Read More

World’s First Long-Term Implantable Glucose Monitoring Device Now FDA Approved

GERMANTOWN, Md., June 21, 2018 — Senseonics Holdings, Inc. (NYSE American: SENS) today announced the U.S. Food and Drug Administration has approved its Pre-market Approval (PMA) application to market the company’s Eversense® Continuous Glucose Monitoring (CGM) System to people with diabetes in the United States. The system is the first and only CGM system to feature…

Read More

Medtronic Receives Expanded Indication for Kyphon HV-R Bone Cement

Medtronic seems to be on a roll when it comes to innovation. The Dublin-based company has received the greenlight from FDA for an expanded indication of the Kyphon HV-R Bone Cement. Under the new indication, Medtronic can market Kyphon for the fixation of pathological fractures of the sacral vertebral body using sacral vertebroplasty or sacroplasty.…

Read More

GE Booted From the Dow After More Than 100 Years

For the first time in 110 years, General Electric will not be a member of the elite Dow Jones Industrial Average. S&P Dow Jones Indices announced on Tuesday that the iconic maker of light bulbs and jet engines will be replaced in the 30-stock index by Walgreens Boots Alliance. GE (GE) was an original member of the…

Read More

Scammers Trick Seniors with ‘Free’ Medical Devices, Then Bill Medicare

Nancy DeLozier looked at the array of medical equipment on the floor of her living room and called it junk. The 84-year-old Northwest Side woman said she received the items in the mail but neither wants nor needs them. One shipment, from February 2017, included a back brace and knee braces. A second shipment, which…

Read More

MIT’s 3D Printed Walking, Drug-Transporting Magnets

MIT engineers have created soft, 3-D-printed structures whose movements can be controlled with a wave of a magnet, much like marionettes without the strings. The menagerie of structures that can be magnetically manipulated includes a smooth ring that wrinkles up, a long tube that squeezes shut, a sheet that folds itself, and a spider-like “grabber”…

Read More

Doctors Told Not to Order ECG’s for Low-Risk Patients

Doctors shouldn’t routinely perform electrocardiograms on patients at low risk for heart disease, an influential federal panel is recommending. While an ECG test of the heart’s electrical activity is safe and inexpensive, the benefits for patients at low risk of heart disease are very low and the results can trigger possibly dangerous, unnecessary follow-up testing…

Read More

Implantable Device Delivers Drugs Straight to the Heart

An international team of researchers, led by Harvard University, have developed a refillable, implantable device, which sits directly on the heart and can deliver drugs and other therapies to treat the aftereffects of a heart attack. The device, dubbed Therepi, is a small patch that is sutured onto the heart. The patch contains a sponge-like…

Read More

Intuitive Surgical Invests $15m Into Lung Cancer Startup

Intuitive Surgical has struck a deal with lung disease technology firm Broncus Medical. The multipart agreement includes a $15 million investment, technology development collaboration and a licensing deal. Broncus has built its business upon a portfolio of technology platforms that support the diagnosis of lung cancer and treatment of emphysema. These devices provide image guidance to help…

Read More